Evidence map›Paper›PMID 38400945›Full record

ArticleObesity surgery2024

The Management of Biliary Disease in Patients with Severe Obesity Undergoing Metabolic and Bariatric Surgery-An International Expert Survey.

Mohammad Kermansaravi, Scott Shikora, Bruno Dillemans, Marina Kurian, Teresa LaMasters, Ramon Vilallonga, Gerhard Prager, Sonja Chiappetta, MOGIPSO Collaborators

Abstract read
PubMed Publisher
In one paragraph

Article in Obesity surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 6 countries.

Mohammad KermansaraviDivision of Minimally Invasive and Bariatric Surgery, Department of Surgery, Hazrat-E Fatemeh Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. mkermansaravi@yahoo.com.
Scott ShikoraBrigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Bruno DillemansDepartment of General Surgery, AZ Sint Jan Brugge-Oostende, Brugge, Belgium.
Marina KurianDepartment of Surgery, NYU Langone Medical Center, New York, NY, 10016, USA.
Teresa LaMastersUnityPoint Clinic Weight Loss Specialists, West Des Moines, IA, USA.
Ramon VilallongaEndocrine, Bariatric and Metabolic Surgery Department, University Hospital Vall Hebron, Barcelona, Spain.
Gerhard PragerDivision of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Vienna, Austria.
Sonja ChiappettaBariatric and Metabolic Surgery Unit, Department of General and Laparoscopic Surgery, Ospedale Evangelico Betania, Via Argine 604, 80147, Naples, Italy. drschiappetta@gmail.com.ORCID 0000-0002-1964-416X
MOGIPSO Collaborators
AZ Sint-Jan · BEBrigham and Women's Hospital · USIran University of Medical Sciences · IRMedical University of Vienna · ATNYU Langone Health · USRegione Campania · ITUnityPoint Health · USVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to survey international experts in metabolic and bariatric surgery (MBS) to improve and consolidate the management of biliary disease in patients with severe obesity undergoing MBS.

backgroundObesity and rapid weight loss after MBS are risk factors for the development of gallstones. Complications, such as cholecystitis, acute cholangitis, and biliary pancreatitis, are potentially life-threatening, and no guidelines for the proper management of gallstone disease exist.

methodsAn international scientific team designed an online confidential questionnaire with 26 multiple-choice questions. The survey was answered by 86 invited experts (from 38 different countries), who participated from August 1, 2023, to September 9, 2023.

resultsTwo-thirds of experts (67.4%) perform concomitant cholecystectomy in symptomatic gallstones during MBS. Half of experts (50%) would wait 6-12 weeks between both surgeries with an interval approach. Approximately 57% of the experts prescribe ursodeoxycholic acid (UDCA) prophylactically after MBS, and most recommend a 6-month course. More than the half of the experts (59.3%/53.5%) preferred laparoscopic assisted transgastric ERCP as the approach for treating CBD stones in patients who previously had RYGB/OAGB.

conclusionConcomitant cholecystectomy is preferred by the experts, although evidence in the literature reports an increased complication rate. Prophylactic UDCA should be recommended to every MBS patient, even though the current survey demonstrated that not all experts are recommending it. The preferred approach for treating common bile duct stones is a laparoscopic assisted transgastric ERCP after gastric bypass. The conflicting responses will need more scientific work and clarity in the future.

Indexed as

Bariatric SurgeryCholecystectomy, LaparoscopicGallstonesObesity, MorbidCholangiopancreatography, Endoscopic RetrogradeHumansObesityUrsodeoxycholic AcidUrsodeoxycholic AcidCholecystolithiasisCholedocholithiasisCholelithiasisCommon bile duct stonesEndoscopic retrograde cholangiopancreatographyGallstone diseaseGallstones

Identifiers

PMID38400945
OpenAlexW4392131655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.